119 related articles for article (PubMed ID: 16575256)
1. Prolonged seated immobility-associated venous coagulability in a factor V Leiden heterozygote: a case-comparative study.
Ansari MT; Cheung BM; Karlberg JP
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):187-91. PubMed ID: 16575256
[TBL] [Abstract][Full Text] [Related]
2. The association between seated immobility and local lower-limb venous coagulability in healthy adult volunteers: a simulation of prolonged travel immobility.
Ansari MT; Mahmood MT; Karlberg JP
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):335-41. PubMed ID: 16788308
[TBL] [Abstract][Full Text] [Related]
3. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.
Chaireti R; Jennersjö C; Lindahl TL
Thromb Res; 2009 Jun; 124(2):178-84. PubMed ID: 19232683
[TBL] [Abstract][Full Text] [Related]
4. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
Gessoni G; Valverde S
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
[TBL] [Abstract][Full Text] [Related]
6. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
[TBL] [Abstract][Full Text] [Related]
7. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
[TBL] [Abstract][Full Text] [Related]
8. The role of plasminogen activator inhibitor-1 polymorphism, factor-V-Leiden, and prothrombin-20210 mutations in pulmonary thromboembolism.
Oguzulgen IK; Yilmaz E; Demirtas S; Erkekol FO; Ekim N; Demir N; Numanoglu N; Ozel D; Ulu A; Akar N
Clin Appl Thromb Hemost; 2009 Feb; 15(1):73-7. PubMed ID: 18160588
[TBL] [Abstract][Full Text] [Related]
9. Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study.
Oger E; Lacut K; Le Gal G; Couturaud F; Abalain JH; Mercier B; Mottier D;
Thromb Res; 2007; 120(2):207-14. PubMed ID: 17126889
[TBL] [Abstract][Full Text] [Related]
10. Factor V leiden increases plasma F1+2 levels both in normal and deep venous thrombosis subjects.
Mercuri F; Giacomello R; Puglisi F; Colaone R; Fabbro D; Menegon MG; Ceriello A; Gonano F; Damante G
Haematologica; 2000 Apr; 85(4):386-9. PubMed ID: 10756364
[TBL] [Abstract][Full Text] [Related]
11. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population.
Torres JD; Cardona H; Alvarez L; Cardona-Maya W; Castañeda SA; Quintero-Rivera F; Cadavid A; Bedoya G; Tobón L
Am J Hematol; 2006 Dec; 81(12):933-7. PubMed ID: 16917913
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients.
Dölek B; Eraslan S; Eroğlu S; Kesim BE; Ulutin T; Yalçiner A; Laleli YR; Gözükirmizi N
Clin Appl Thromb Hemost; 2007 Oct; 13(4):435-8. PubMed ID: 17911197
[TBL] [Abstract][Full Text] [Related]
13. Haemostatic changes in laparoscopic cholecystectomy: a comparison between upper and lower limb measurements.
Khairy G; Al Ghumlas A; Al Dohayan A; Gader AG
Surg Laparosc Endosc Percutan Tech; 2010 Apr; 20(2):79-83. PubMed ID: 20393332
[TBL] [Abstract][Full Text] [Related]
14. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.
Procare-GEHT Group
Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352
[TBL] [Abstract][Full Text] [Related]
15. Factor V Leiden mutation in relation to fecundity and miscarriage in women with venous thrombosis.
van Dunné FM; Doggen CJ; Heemskerk M; Rosendaal FR; Helmerhorst FM
Hum Reprod; 2005 Mar; 20(3):802-6. PubMed ID: 15618258
[TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
Strandberg K; Svensson PJ; Ohlin AK
Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343
[TBL] [Abstract][Full Text] [Related]
17. Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.
Abramson N; Costantino JP; Garber JE; Berliner N; Wickerham DL; Wolmark N
J Natl Cancer Inst; 2006 Jul; 98(13):904-10. PubMed ID: 16818854
[TBL] [Abstract][Full Text] [Related]
18. Endogenous thrombin potential for predicting risk of venous thromboembolism in carriers of factor V Leiden.
Lincz LF; Lonergan A; Scorgie FE; Rowlings P; Gibson R; Lawrie A; Seldon M
Pathophysiol Haemost Thromb; 2006; 35(6):435-9. PubMed ID: 17565236
[TBL] [Abstract][Full Text] [Related]
19. [Combination of heterozygote blood coagulation factor V Leiden carriage with erythrocytosis as a cause of the hip deep vein thrombosis].
Idelson LI; Albert II; Rudensky B; Levy-Lahad E; Renbaum P; Klein G
Ter Arkh; 2002; 74(2):66-70. PubMed ID: 11899832
[TBL] [Abstract][Full Text] [Related]
20. Ocular vascular thrombotic events: a diagnostic window to familial thrombophilia (compound factor V Leiden and prothrombin gene heterozygosity) and thrombosis.
Glueck CJ; Wang P
Clin Appl Thromb Hemost; 2009 Feb; 15(1):12-8. PubMed ID: 18796459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
